When I was a youngster, my family raised chickens for a supplement to our income. The poultry industry was prominent in our part of the country, and I grew up well versed in the ways of chickens. In a “house” of several thousand chickens, there would always be a few dozen “culls” that would eventually die prematurely or be ”culled” out and destroyed because they couldn’t survive in the chicken mainstream. These culls were usually small, late developing, and not able to compete for position and time around the feed troughs and water sources. Had the other chickens accommodated the cull, it would have thrived and perhaps become the top chicken of the bunch. When I see the inability of complementary cancer therapy to compete for research grants and places at the mainstream medical science table, I am always reminded of my chicken raising days and the plight of the cull chicken.